Modulation of angiogenesis in a model of chronic inflammation

Inflammation Research

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Jackson, J R ^a   Bolognese, B ^a   Kircher, C H ^a   Marshall, L A ^a   Winkler, J D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; MEDROXYPROGESTERONE; PROTAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHRONIC INFLAMMATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOMA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

AIR; ANIMALS; CROTON OIL; DISEASE MODELS, ANIMAL; FEMALE; GRANULOMA; INTERLEUKIN-1; MEDROXYPROGESTERONE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PROTAMINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030847525     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Colville-Nash PR, Seed MP. The current state of angiostatic therapy, with special reference to rheumatoid arthritis. Curr Opin Invest Drugs 1993;2:763-813.
2. Jackson JR. Angiogenesis and inflammation. Pharmacol Comm 1996; in press.
3. BenEzra D, Maftzir G. Antibodies to IL-I1 and YNF-alpha but not to bFGF or VEGF inhibit angiogenesis. Invest Ophthal Vis Sci 1996;37:4664.
4. Colville-Nash PR, Alam CAS, Applelon I, Browne JR, Seed MP, Willoughby DA. The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J Pharmacol Exp Ther 1995;274:1463-72.
5. Kimura M, Amemiya K, Yamada T, Suzuki J. Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice. J Pharmacobio Dyn 1986;9:442-6.
6. Taylor S, Folkman J. Protamine is an inhibitor of angiogenesis. Nature 1982;297:307-12.
7. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DST, Folkman J. Inhibition of tumor growth, vascularization and collagenolysis in rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 1981;78:1176-80.
8. 2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock. J Pharm Exp Ther 1995;274:1254-62.